Cyclerion Therapeutics, Inc.

NasdaqCM:CYCN Stock Report

Mkt Cap: US$27.4m

Cyclerion Therapeutics Management

How experienced are the management team and are they aligned to shareholders interests?


Average management tenure


Peter Hecht (58 yo)





Dr. Peter M. Hecht, Ph D., served as the Chief Executive Officer of Ironwood Pharmaceuticals, Inc. since 1998 until April 1, 2019. Dr. Hecht is Chief Executive Officer and Director of Cyclerion Therapeutic...

CEO Compensation Analysis

How has Peter Hecht's remuneration changed compared to Cyclerion Therapeutics's earnings?
DateTotal Comp.SalaryCompany Earnings
Sep 30 2022n/an/a


Jun 30 2022n/an/a


Mar 31 2022n/an/a


Dec 31 2021US$108kUS$100k


Sep 30 2021n/an/a


Jun 30 2021n/an/a


Mar 31 2021n/an/a


Dec 31 2020US$366kUS$104k


Sep 30 2020n/an/a


Jun 30 2020n/an/a


Mar 31 2020n/an/a


Dec 31 2019US$122kUS$71k


Sep 30 2019n/an/a


Jun 30 2019n/an/a


Mar 31 2019n/an/a


Dec 31 2018US$5mUS$100k


Compensation vs Market: Peter's total compensation ($USD108.22K) is below average for companies of similar size in the US market ($USD727.78K).

Compensation vs Earnings: Peter's compensation has been consistent with company performance over the past year.

Leadership Team

Peter Hecht
CEO & Director3.75yrsUS$108.22k4.71%
$ 1.3m
Cheryl Gault
Chief Operating Officer2yrsUS$664.35k0.032%
$ 8.8k
Anjeza Gjino
CFO & Corporate Secretary3.08yrsno datano data
Todd Milne
Senior Vice President of External Innovation1yrno datano data
Jessica Rennekamp
Associate Director of Corporate Communicationsno datano datano data


Average Tenure


Average Age

Experienced Management: CYCN's management team is considered experienced (2.5 years average tenure).

Board Members

Peter Hecht
CEO & Director3.75yrsUS$108.22k4.71%
$ 1.3m
Terrance McGuire
Independent Director3.75yrsUS$75.99k0.016%
$ 4.3k
George Conrades
Independent Director3.75yrsUS$75.49k0.010%
$ 2.7k
Errol B. De Souza
Independent Director1.75yrsUS$56.58k0%
$ 0
Marsha Fanucci
Independent Chairman3.83yrsUS$94.49k0.039%
$ 10.7k
Ole Isacson
Independent Director3.75yrsUS$70.49k0.0056%
$ 1.5k
Mark Currie
Chair of Scientific Advisory Boardno dataUS$366.78kno data
Stephanie Lovell
Independent Director3.75yrsUS$67.99k0.0056%
$ 1.5k
Michael Mendelsohn
Independent Director3.75yrsUS$74.49k0.0056%
$ 1.5k
Christopher Wright
Member of Clinical Advisory Board1.83yrsUS$767.08kno data
Andrew Budson
Member of Clinical Advisory Board2yrsno datano data
Eric Smith
Member of Clinical Advisory Board2yrsno datano data


Average Tenure


Average Age

Experienced Board: CYCN's board of directors are considered experienced (3.8 years average tenure).